PodcastIntel
Sign in Get Started Free
Front Burner
Front Burner

New Alzheimer's drug met with hope and caution

Dec 1, 2022 · 00:22:54
AI Summary
  • New Alzheimer's drug lecanemab shows promising trial results.
  • Drug slowed cognitive decline by 27% in early stages.
  • Hope and caution surround treatment for Alzheimer's disease.

More from Front Burner

Front Burner
Apr 9, 2026 · 00:30:39
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Front Burner and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →